Share Structure - Updated September 14, 2024
Verified Company Profile
Transfer Agent Verified
No change - no dilution since the 100M reduction on April 23 - 144 days
Authorized Shares:22,000,000,000
Outstanding Shares: 12,760,268,251
Restricted: 940,101,702
Unrestricted: 11,820,166,549
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading
Note 2: Only one convertible note holder remaining that has agreed not to convert their debt into shares until 2025 [latest source: PR dated June 24, 2024]
Note 3: More share cancellations planned [source: 'X' update April 29, 2024]
Note 4: Intention for share buyback ahead confirmed [latest source: PR June 24, 2024]
Note 5: No reverse split confirmed again (for the 9th time) [latest source: PR June 24, 2024]
Note 6: The company has now received approval to use the non-dilutive EB-5 Immigrant Investor Program to raise $20M for its current projects [latest source: 2024 Shareholder Update Letter]
Note 7: The company also has a comprehensive plan to raise $100M for future acquisitions and investments
Note 8: The company also has secondary funding of $50M coming in to support its African, Canadian and US 6-picture film slate [source: Update on March 14, 2024]
Note 9: Market capitalization is projected to surpass $200 Million - fulfilling a criteria for uplisting [latest source: 2024 Shareholder Update Letter]
Note 10: Even before the future planned reductions and later share buyback, a market cap of $200M (higher expected) divided by the current Outstanding Shares would equate to a pps of .0156
Note 11: ABA assets sold for $4.5M - update coming latter this month regarding use of these funds - eg what portion might be used for a share buyback [source: Update on September 10]
Note 12: A buyback of 50% of the float is now also planned. This would reduce the O/S by 4.9 Billion leaving 7.8 Billion and for a market cap of $200M would equate to a pps of .0256 [source: update July 31, 2024]
Verified Company Profile
Transfer Agent Verified
No change - no dilution since the 100M reduction on April 23 - 144 days
Authorized Shares:22,000,000,000
Outstanding Shares: 12,760,268,251
Restricted: 940,101,702
Unrestricted: 11,820,166,549
Note 1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading
Note 2: Only one convertible note holder remaining that has agreed not to convert their debt into shares until 2025 [latest source: PR dated June 24, 2024]
Note 3: More share cancellations planned [source: 'X' update April 29, 2024]
Note 4: Intention for share buyback ahead confirmed [latest source: PR June 24, 2024]
Note 5: No reverse split confirmed again (for the 9th time) [latest source: PR June 24, 2024]
Note 6: The company has now received approval to use the non-dilutive EB-5 Immigrant Investor Program to raise $20M for its current projects [latest source: 2024 Shareholder Update Letter]
Note 7: The company also has a comprehensive plan to raise $100M for future acquisitions and investments
Note 8: The company also has secondary funding of $50M coming in to support its African, Canadian and US 6-picture film slate [source: Update on March 14, 2024]
Note 9: Market capitalization is projected to surpass $200 Million - fulfilling a criteria for uplisting [latest source: 2024 Shareholder Update Letter]
Note 10: Even before the future planned reductions and later share buyback, a market cap of $200M (higher expected) divided by the current Outstanding Shares would equate to a pps of .0156
Note 11: ABA assets sold for $4.5M - update coming latter this month regarding use of these funds - eg what portion might be used for a share buyback [source: Update on September 10]
Note 12: A buyback of 50% of the float is now also planned. This would reduce the O/S by 4.9 Billion leaving 7.8 Billion and for a market cap of $200M would equate to a pps of .0256 [source: update July 31, 2024]
VALIANT EAGLE INC. (PSRU) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.